Aurobindo Pharma Q1 FY26 PAT slips 10% YoY to Rs. 824 Cr
KIMS Q1 FY26 consolidated profit slips to Rs. 78.6 Cr
Morepen Laboratories consolidated Q1 FY26 PAT lower at Rs. 11.40 Cr
Divis Laboratories posts consolidated Q1 FY26 PAT of Rs. 545 Cr
Gandhar Oil Refinery (India) reports Q1 FY26 consolidated PAT lower at Rs. 26.1 Cr YoY
Wockhardt reports Q1 FY26 loss at Rs. 108 Cr
Suraksha Diagnostic reports Q1 FY26 PAT higher by 20% at Rs. 9.1 Cr
Cupid Q1 FY26 PAT jumps 82% at Rs. 15 Cr
Zydus receives final approval from USFDA for Prucalopride Tablets
Biocon Q1 FY26 PAT slips 95% to Rs. 31.4 Cr
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes